课题基金 / 基金详情

EVALUATION OF EFFECT OF COMPLEMENTARY DRUG REGIMEN ON CORONARY ARTERIOSCLEROSIS

EVALUATION OF EFFECT OF COMPLEMENTARY DRUG REGIMEN ON CORONARY ARTERIOSCLEROSIS
补充药物治疗方案对冠状动脉硬化的疗效评估
批准号:
6246354
负责人:
JOHN P KANE
金额:
$4.89万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-04 至 1997-11-30

项目摘要

项目成果

JOHN P KANE的其他基金

相关文献

中文摘要
翻译
这些研究是协议#20-1的一个内容,除了 添加普罗布考作为其中一种药物。因为我们现在可以使低密度脂蛋白正常化 杂合性家族性高胆固醇血症患者的胆固醇水平 使用联合用药方案,我们正在测试该方案的能力 通过计算机血管造影术测量,缩小动脉粥样硬化斑块。 研究了治疗对患者血浆游离水平的影响 脂肪酸。
英文摘要
These studies are a contiuation of protocol #20-1, except fo rthe addition of probucol as one of the drugs. Since we can now normalize LDL cholesterol in patients with heterzygous familial hypercholesterolemia using a combined drug regimen, we are testing the regimen's ability to shrink atherosclerotic plaques as measured by computerized angiography. Patients are studied in the effect of treatment on levels of plasma free fatty acid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF THE PROTEIN COMPOSITION OF ARTERIOSCLEROTIC PLAQUES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES